Home » Director of International Vaccines: Vaccination with Sinopharm or Sinopharm is more susceptible to Omicron virus | CCP virus | Omikron | Sinopharm | Sinopharm | Sinopharm vaccine | Sinopharm vaccine |

Director of International Vaccines: Vaccination with Sinopharm or Sinopharm is more susceptible to Omicron virus | CCP virus | Omikron | Sinopharm | Sinopharm | Sinopharm vaccine | Sinopharm vaccine |

by admin

[Voice of Hope, January 10, 2022](Comprehensive compilation by our reporter Yuning)At a time when the Omicron variant of the CCP virus is rapidly spreading across Europe, North America, Australia and Asia, Jerome Kim, director of the International Vaccine Institute, said that because Asian countries mainly use It is the Chinese-made Kexing and Sinopharm CCP virus vaccines to fight the epidemic, which makes people in these countries more likely to be infected with the Omicron variant virus.

According to the ABC’s report on January 11 (Tuesday), since many Asian countries have realized that travel bans and strict epidemic control measures cannot completely prevent the invasion of the CCP virus, they have begun to give their people a large area under the temptation of the CCP’s vaccine diplomacy. Inoculated with Sinovac and Sinopharm vaccines produced by the CCP. Both vaccines are widely available in more than 30 Asian countries.

However, Jerome King, director of the International Vaccine Institute, said that because of the lower efficacy of Sinovac and Sinopharm vaccines, people in Asia who received these coronavirus vaccines are more vulnerable to the disease.

He said: “If we only look at the level of neutralizing antibodies (in humans), the antibodies elicited by Sinovac and Sinopharm vaccines were at low levels to begin with. Before the outbreak of the Omikron variant, people You need a booster.”

A Hong Kong study also found that three doses of the Sinovac vaccine failed to elicit sufficient levels of antibodies in humans to fight off the Omicron variant.

See also  The treatment of 300 children under 6 years old in Shanghai is highly valued

A Yale University study found that people who received two doses of the Sinovac vaccine, and then received a Pfizer booster, were unable to protect against the invasion of the Omicron variant. The study’s researchers suggested that people who received two doses of Sinovac vaccine would need two more booster doses of Pfizer’s vaccine for adequate protection.

The report said that the Modena vaccine, the Aliscon vaccine and the Pfizer vaccine also need boosters to better protect against the invasion of the Omicron Metamorphosis virus.

Some Asian countries had already switched to other vaccines before the Omikron Variant Virus outbreak. For example, Thailand now requires citizens who have received two doses of the Sinovac vaccine to receive two more doses of Sinovac, or allow people to receive two doses of Sinovac. On the basis of two doses of Sinovac vaccine, Aliscon vaccine was changed.

However, Indonesia is still giving its children between the ages of 6 and 11 a dose of the Sinovac vaccine, the only coronavirus vaccine currently approved for children in the country. Jerome King therefore estimates that many Indonesians will contract the Omicron variant of the virus.

“Many people who have been vaccinated may also get the disease,” he said. “However, some data suggest that the Omikron variant may not be very virulent and people’s symptoms are not severe.”

Editor in charge: Zhang Lili

This article or program has been edited and produced by Voice of Hope. Please indicate Voice of Hope and include the original title and link when reprinting.

See also  Movida, degradation and attacks, residents and traders mobilize

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy